BOSTON, April 29, 2025--(BUSINESS WIRE)--Ensoma, a genomic medicines company advancing the future of medicine through one-time, in vivo therapies designed to precisely and durably engineer the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback